# Zirabev

NDC: 0069-0342
Generic name: bevacizumab-bvzr
Labeler / Manufacturer: Pfizer Laboratories Div Pfizer Inc
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION, SOLUTION
Routes: INTRAVENOUS
Marketing started: 20200113

FDA application: BLA761099

## Active ingredients

- BEVACIZUMAB: 400 mg/16mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0069-0342"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0069-0342
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=aa27acbd-d117-4350-aeee-17bc2e2c0ca4